These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 215062)

  • 1. Equine rhinopneumonitis vaccine: immunogenicity and safety in foals.
    Purdy CW; Porter RC; Ford SJ
    Am J Vet Res; 1978 May; 39(5):745-52. PubMed ID: 215062
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Efficacy of modified live-virus equine rhinopneumonitis vaccine.
    Stear RL; Bass EP; Beckenhauer WH
    Am J Vet Res; 1976 Mar; 37(3):349-51. PubMed ID: 176909
    [No Abstract]   [Full Text] [Related]  

  • 3. Equine rhinopneumonitis vaccine: immunogenicity and safety in adult horses, including pregnant mares.
    Purdy CW; Ford SJ; Porter RC
    Am J Vet Res; 1978 Mar; 39(3):377-83. PubMed ID: 205144
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunity and the level of neutralization antibodies in foals and mares vaccinated with a modified live-virus rhinopneumonitis vaccine.
    Dutta SK; Shipley WD
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):445-8. PubMed ID: 164808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of pregnant ponies against equine rhinopneumonitis.
    Crandell RA; Mock RE; Lock TF
    Am J Vet Res; 1980 Jul; 41(7):994-6. PubMed ID: 6254412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
    Fitzpatrick DR; Studdert MJ
    Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture.
    Eaglesome MD; Henry JN; McKnight JD
    Can Vet J; 1979 May; 20(5):145-7. PubMed ID: 226261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EHV1, to vaccinate or not?].
    Binkhorst GJ; van Oirschot JT; Breukink HJ
    Tijdschr Diergeneeskd; 1985 Mar; 110(5):189-90. PubMed ID: 2984805
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
    Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
    Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and antibody responses to equine herpesviruses 1 and 4.
    Studdert MJ
    J Am Vet Med Assoc; 1995 Sep; 207(6):698-701. PubMed ID: 7657564
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vaccination against the paralytic form of EHV1?].
    Breukink HJ; Binkhorst GJ; van Oirschot JT
    Tijdschr Diergeneeskd; 1983 May; 108(9):359. PubMed ID: 6306862
    [No Abstract]   [Full Text] [Related]  

  • 12. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
    Bryans JT; Allen GP
    Dev Biol Stand; 1982; 52():493-8. PubMed ID: 6299858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of RhinoquinTM, rhinopneumonitis vaccine in foals and pregnant mares.
    Purdy CW
    Vet Med Small Anim Clin; 1977 Sep; 72(9):1478, 1480. PubMed ID: 199978
    [No Abstract]   [Full Text] [Related]  

  • 14. [Application of the passive hemagglutination test to the study of equine rhinopneumonitis. II. Serologic study in horses].
    Berrios P; Ibarra L; Riquelme S
    Rev Latinoam Microbiol; 1986; 28(4):339-43. PubMed ID: 3035677
    [No Abstract]   [Full Text] [Related]  

  • 15. [Equine rhinopneumonitis virus infection in horses. II (author's transl)].
    Dijkstra RG; de Boer GF
    Tijdschr Diergeneeskd; 1976 May; 101(9):494-7. PubMed ID: 178066
    [No Abstract]   [Full Text] [Related]  

  • 16. [Year-round antibody profile of groups of horses of a herd kept in isolation after differently terminating use of an experimental viral combination vaccine].
    Bürki F; Nowotny N; Hofer A
    Dtsch Tierarztl Wochenschr; 1991 Mar; 98(3):82-9. PubMed ID: 1646100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a vaccine against equine herpesvirus 1.
    Sabine M; Whalley JM
    Aust Vet J; 1989 Dec; 66(12):403-4. PubMed ID: 2559691
    [No Abstract]   [Full Text] [Related]  

  • 18. Rhinomune (rhinopneumonitis vaccine).
    Lloyd-Evans LP
    Vet Rec; 1982 Oct; 111(17):401. PubMed ID: 6294955
    [No Abstract]   [Full Text] [Related]  

  • 19. Equine herpesvirus.
    Vet Rec; 1989 May; 124(19):519. PubMed ID: 2547266
    [No Abstract]   [Full Text] [Related]  

  • 20. Control of EHV-1 viremia and nasal shedding by commercial vaccines.
    Goehring LS; Wagner B; Bigbie R; Hussey SB; Rao S; Morley PS; Lunn DP
    Vaccine; 2010 Jul; 28(32):5203-11. PubMed ID: 20538091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.